MHRA finds evidence does not support a link between Glucagon-Like Peptide-1 (GLP-1) receptor agonists and suicidal and self-injurious thoughts and actions Following a thorough review, the Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that the available evidence does not establish a causal relationship between Glucagon-Like Peptide-1 (GLP-1) receptor agonists and suicidal behaviour, suicidal ideation, self-injury and depression
Fernndez-Torres, R., Ruiz-Muoz, M., Prez-Panero, A
Vitamin C consumption does not impair training-induced improvements in exercise performance
Tretter L, Adam-Vizi V (2004) Generation of reactive oxygen species in the reaction catalyzed by alpha-ketoglutarate dehydrogenase
Important considerations: 5-HTP interactions: If you take SSRIs, MAOIs, or other medications affecting serotonin, consult your healthcare provider before use Berberine interactions: Berberine may interact with certain medications, including those for diabetes and blood pressure Pregnancy and nursing: Not recommended Age: Formulated for adults only When to talk to your doctor first: If you have diabetes, prediabetes, or blood sugar management concerns If you take medications for any chronic condition If you have a history of eating disorders If you experience any adverse reactions This is not a replacement for prescribed medical treatment
Health effects of dietary risks in 195 countries, 19902017: a systematic analysis for the Global Burden of Disease Study 2017
